DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells
about
Recent advances on the use of biochemical extracts as filaricidal agentsAndrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacologyApoptosis inducing effect of andrographolide on TD-47 human breast cancer cell lineIsolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian)Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer.Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculataCytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth.Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell lineBenzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G(1) arrest and apoptosis.Therapeutic Potential of Andrographolide Isolated from the Leaves of Andrographis paniculata Nees for Treating Lung Adenocarcinomas.Inhibition of tumor progression by naturally occurring terpenoids.Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells.Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.Andrographolide: a new plant-derived antineoplastic entity on horizonAndrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells.
P2860
Q26830064-3B56A1E3-C539-4B7D-8883-490160A5FF44Q28261671-6FB85F6D-1BD9-4882-B3C7-36E3E9D307FAQ33531828-5199B815-3916-461A-A91B-E6E6386A1A82Q33898543-69F6DCB6-273D-4A51-8D47-6712EB03F69EQ34053857-1FEC4251-FFF0-4F1C-B301-7E66433EBC2CQ34168689-01B3A8E5-5D64-4AC2-824E-623D9E6CFC8AQ34614630-017B27ED-23E4-4F86-A1CB-A4634605A34CQ35105163-39D83FC1-F523-4850-80B7-B7AD0E6699E7Q36804628-3AAE9EDA-F520-46A3-9748-5856B4344788Q36977487-ACB09788-EB0C-42F4-85CB-80E17BB00B6DQ37127216-2E2B22AB-8D48-4410-B2FA-6596FC285252Q37936436-44B57E4E-02F3-4901-AC2F-8BA82369F96BQ38835376-2C0CAF92-91EB-41F4-838E-CF3286DAD508Q38984139-AE0A470D-8568-43C2-9216-58233057C50BQ39947303-56B2131F-2D3C-4CBB-BFAA-2E7368DD994FQ41895046-1D92A8AC-F584-4E18-9394-4B9826ABAC6C
P2860
DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@ast
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@en
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@nl
type
label
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@ast
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@en
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@nl
prefLabel
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@ast
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@en
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@nl
P2093
P2860
P3181
P356
P1433
P1476
DRF 3188 a novel semi-syntheti ...... e to MCF 7 breast cancer cells
@en
P2093
Chitkala Satyanarayana
Dhanavanthri S Deevi
Nanduri Srinivas
R Rajagopalan
Sriram Rajagopal
P2860
P2888
P3181
P356
10.1186/1471-2407-4-26
P407
P577
2004-06-18T00:00:00Z
P5875
P6179
1009894639